Segra is at the forefront of agricultural technology (ag-tech) innovation in the cannabis industry, specializing in plant tissue culture and genetic identification. Their advanced services include the production of disease-free plantlets and the use of proprietary DNA fingerprinting techniques, which ensure high-quality genetic assurance for growers. Segra's extensive library of cannabis cultivars, curated by leading genetic providers, allows customers to optimize their genetic portfolios, enhancing both efficiency and profitability in cannabis cultivation. The company emphasizes the importance of innovation in breeding efficiency and the development of best-in-class diagnostics tools to identify and manage plant pathogens effectively.

In addition to their focus on plant tissue culture, Segra is committed to advancing plant genomics through research initiatives led by experienced scientists. Their capabilities include in-house diagnostics for pathogen detection, which are crucial for maintaining the health of nursery stock. By developing bioinformatics systems and marker-assisted selection breeding programs, Segra aims to provide growers with the tools necessary to make informed decisions and improve their operations. Overall, Segra's combination of cutting-edge technology and scientific expertise positions them as a leader in the cannabis ag-tech sector, dedicated to driving growth and innovation for their partners.

Canada

Segra is a biotechnology company that specializes in industrial-scale plant micropropagation also known as “plant tissue culture.” The company is developing industrial-scale micropropagation laboratories to produce healthy, robust plantlets for growers and licensed cannabis producers globally.

Our solution:

Segra leverages expertise in plant tissue culture, biochemistry, botany, genetic testing, and production under strict regulatory environments to bring end-to-end solutions for product production and sale in the agriculture space.

Investors:  info@segra-intl.com

Segra

Company Details